Overview

Enoxaparin as Treatment for Vulvodynia

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that injections of Low molecular weight heparin (LMWH) [enoxaparin] will reduce pain in women with vulvodynia.
Phase:
Phase 2
Details
Lead Sponsor:
Western Galilee Hospital-Nahariya
Treatments:
Enoxaparin